Last reviewed · How we verify

NCT03584100

Effect of Pneumatic Tourniquet on Arm Swelling After Lymph Node Removal

Completed NA Results posted Last updated 13 December 2023
What this trial tests

NA trial testing Tourniquet 8000 in Healthy Subject in 12 participants. Completed in 30 June 2020.

Timeline
7 November 2018
Primary endpoint
30 June 2020
30 June 2020

Quick facts

Lead sponsorStanford University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment12
Start date7 November 2018
Primary completion30 June 2020
Estimated completion30 June 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Stanford University

Who can join

19 and older, any sex, with Healthy Subject. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Change in Hand Volume Following Tourniquet Use Primary · 30 minutes after tourniquet use

Hand volume, as an indicator of limb edema / fluid accumulation, was determined with an aqueous volumeter at rest and for the sling and elevated arm positions 30 minutes after an arm tourniquet was placed. Measurements were taken for the affected arm \[ie, after axillary lymph node dissection (ALND)\], and the same patient's contralateral arm (control, ie, "other arm"). The mean values for each arm (affected vs control) of the participant group, before (baseline) and 30 minutes after placement of the pneumatic tourniquet were obtained. The difference represents the effect of tourniquet placem

Mean Difference in Hand Volume, Elevated Position
GroupValue95% CI
Change in Hand Volume Following Tourniquet Use in Axillary Lymph Node Dissection (ALND) Arm15.0± 8.5
Change in Hand Volume Following Tourniquet Use in Contralateral Arm12.1± 5.4
Mean Difference in Hand Volume, Sling Position
GroupValue95% CI
Change in Hand Volume Following Tourniquet Use in Axillary Lymph Node Dissection (ALND) Arm12.5± 8.9
Change in Hand Volume Following Tourniquet Use in Contralateral Arm7.9± 6.9
Difference in Hand Volume Following Tourniquet Use, Between ALND and Control Limbs Secondary · 30 minutes

Hand volume, as an indicator of limb edema / fluid accumulation, was determined with an aqueous volumeter 30 minutes after an arm tourniquet was placed and the arm held in sling and elevated arm positions. Measurements were taken for the affected arm \[ie, after axillary lymph node dissection (ALND)\], and the same patient's contralateral arm (control, ie, "other arm"). Measurements were compared to the participant's contralateral control ("the other arm") in the same positions. The difference represents to effect of ALND on hand volume. The outcome is reported as the absolute change in mean h

GroupValue95% CI
Difference in Hand Volume, Axillary Lymph Node Dissection (ALND) vs Contralateral Arms, Elevated2.9
Difference in Hand Volume, Axillary Lymph Node Dissection (ALND) vs Contralateral Arms, Sling4.6

Sponsor's own description

The purpose of the proposed study is to evaluate the acute impact of swelling caused by low-pressure tourniquet use in the setting of ipsilateral prior axillary lymph node dissection and the change in swelling reduction following tourniquet use in three limb postures versus healthy volunteers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy Subject

Currently open trials in the same condition.

Other Stanford University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03584100.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing